A benchmark study for the time course of contrast enhancement of Fenestra® VC was performed on a flat-panel eXplore Locus and an injection dose of 10 mL/kg. Peak enhancement in C57 mice hearts occurred 0.25 hours with a 340 HU enhancement over baseline. Contrast enhancement in the liver reached a value of 290 HU over baseline at the 24 hour time point. Elimination of contrast from the blood pool was calculated to be 8 hours.
The time course of Fenestra® VC makes it ideal for prolonged vascular imaging and retrospective cardiac gating studies.
A recent study offers insights into a novel approach to cardiac repair by inhibiting ENPP1, an enzyme critical to regulating extracellular nucleotide metabolism. MediLumine’s Fenestra
Recent advancements in high-resolution micro CT imaging have opened new doors for researchers, enabling them to explore microvascular structures in unprecedented detail. Unlocking the Power
Copyright © 2024 · MediLumine, Inc · All Rights Reserved
